Tocilizumab inhibits interleukin-6-mediated matrix metalloproteinase-2 and -9 secretions from human amnion cells in preterm premature rupture of membranes.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples